Cart Details

Rsv Test Quickvue Clia Waived Sync Bx/20 (Non Returnable Item)

  • Manufacturer Name : Quidel Corp
  • MFG # : 20193
  • Distributor Name : Cobalt Medical Supply Inc.
PID UOM Price Qty
416763 20/BX
$459.36
Register For Member Price

 

Non Returnable

 

Manufacturer #20193
BrandQuickVue®
ManufacturerQuidel
Country of OriginUnknown
ApplicationRespiratory Test Kit
CLIA ClassificationCLIA Waived
CLIA ClassifiedCLIA Waived
Contents 1Test Strips, Extraction Reagent Bottle, Extraction Tubes, Disposable Droppers, Nasopharyngeal Swabs, Positive RSV Control Swab, Negative Control Swab, Package Insert, Quick Reference Instructions
Is_ECATN
Is_GSAY
Is_VAN
Number of Tests20 Tests
Product DatingMcKesson Acceptable Dating: we will ship >= 90 days
Purchase Program TypeStandard Purchase
Reading TypeVisual Read
Sample TypeNasopharyngeal Swab / Nasopharyngeal Wash / Nasopharyngeal Aspirate Sample
SpecialtyImmunoassay
Test FormatDipstick Format
Test Kit TypeRapid
Test MethodLateral Flow Method
Test NameRespiratory Syncytial Virus Test (RSV)
Test TypeInfectious Disease Immunoassay
Time to Results15 Minute Results
UNSPSC Code41116144
Latex Free IndicatorNot Made with Natural Rubber Latex

Features

  • The QuickVue RSV test is a dipstick immunoassay which allows for the rapid, qualitative detection of respiratory syncytial virus (RSV) antigen (viral fusion protein) directly from nasopharyngeal swab or nasopharyngeal aspirate specimens for symptomatic pediatric patients eighteen years of age and younger
  • A single sample can be used to run both the QuickVue RSV test and QuickVue brand Influenza tests
  • 15 minutes to result
  • Built-in internal control
  • Kit includes external controls, positive and negative
  • Kit shelf life of 24 months at room temperature (from date of manufacture)

Frequently Asked Questions(FAQs)

The cost of Rsv Test Quickvue Clia Waived Sync Bx/20 (Non Returnable Item) is $459.36 .
Rsv Test Quickvue Clia Waived Sync Bx/20 (Non Returnable Item) is manufactured by Quidel Corp.
Read More

Subscribe to Our Newsletter